Relapsing polychondritis (RP) is a rare disorder of unknown cause characterized by recurrent episodes of polychondritis and progressive destruction of cartilage of the ear, nose and laryngotracheobronchial tree. 1 As many as 30% of the patients have other autoimmune disorders like systemic vasculitis and rheumatoid arthritis. This observation suggests an essential role of autoimmune reaction in the pathogenesis of RP.
2 Myelodysplastic syndrome is also associated with RP, although its mechanism is unknown. 3, 4 There have been few reports of auto-SCT for RP. [5] [6] [7] We present here for the first time a case of RP treated with non-myeloablative allogenic BMT from sibling donor for myelodysplastic syndrome.
A of marrow nucleated cells and tri-lineage dysplasia. He was diagnosed as having refractory anemia with excess of blasts (RAEB-1). The karyotype was 46, XY. After the diagnosis of RP, he was treated with 10 mg/day of prednisolone. Gallium scintigraphy before the transplantation showed apparent polyarthritis (Figure 1c, left) .
Because of the requirement for frequent red blood cell transfusions, he underwent non-myeloablative allogenic BMT from HLA-matched sibling donor in June 2007. The conditioning regimen consisted of TBI of 12 Gy and fludarabine 30 mg/m 2 for 5 consecutive days, melphalan 70 mg/m 2 2 consecutive days ( Figure 2 ). CYA and shortterm MTX were used for the prophylaxis of GVHD. Because acute GVHD affecting the skin (grade 2) developed on day 27, we transiently prescribed 1 mg/kg of prednisolone. Thereafter, the patient was relieved of the recurrence of myelodysplastic syndrome and showed no manifestation of chronic GVHD even after he discontinued all immunosuppressive agents in 2008.
C-reactive protein declined after the BMT and remained at or less than 0.1 mg/dL except for the episode of documented pneumonia in 2008. The conjunctivitis ameliorated significantly after the non-myeloablative allogenic BMT, and Gallium scintigraphy revealed improvement of the polychondritis. The patient has been free from the recurrence of polychondritis for 3 years. The 5-year mortality of RP is about 30% due to the collapse of airway structure or cardiovascular involvement. The presented case suggests that non-myeloablative allo-BMT from 
